Uplizna 100 mg/10 mL injection Images
Generic Name: inebilizumab
This medication has been identified as Uplizna 100 mg/10 mL injection. It is supplied by Viela Bio, Inc.
Uplizna is used in the treatment of Immunoglobulin G4-Related Disease; Neuromyelitis Optica Spectrum Disorder and belongs to the drug class selective immunosuppressants. Uplizna 100 mg/10 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Uplizna
- Generic Name
- inebilizumab
- Strength
- 100 mg/10 mL injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Viela Bio, Inc.
- National Drug Code (NDC)
- 72677-0551 (Discontinued)
See also:
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Enspryng
Enspryng is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
Epysqli
Epysqli (eculizumab-aagh), a biosimilar to Soliris, targets the complement system to treat ...
Satralizumab
Satralizumab (Enspryng) is used to treat adults with neuromyelitis optica spectrum disorder ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
More about Uplizna (inebilizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.